ENZC Stock: SEC Settlement, Reverse Split, and Biotech Potential

Analyze ENZC stock risks and rewards. Explore Enzolytics' recent SEC settlement, the 500-to-1 reverse split, ITV-1 biotech pipeline, and Pink Sheet risks.